5-Year overall survival in endometrial cancer not improved with chemo-radiotherapy

Adjuvant chemotherapy administered concurrently with and after radiotherapy does not prolong 5-year overall survival among patients with high-risk endometrial cancer, according to a study published in The Lancet Oncology.
Oncology Nurse Advisor